Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | |
| Sales | 246,195 |
| Cost of Goods | 124,697 |
| Gross Profit | 121,490 |
| Operating Expenses | 189,477 |
| Operating Income | -67,282 |
| Interest Expense | 8,936 |
| Other Income | 21,682 |
| Pre-tax Income | -54,536 |
| Income Tax | -514 |
| Net Income Continuous | -54,322 |
| Net Income | $-54,326 |
| EBITDA(a) | $26,538 |